At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Alendronate +2 moredrug
Likely dose
Alendronate 70 mg once weekly, plus Calcium Citrate 600 mg daily, plus Vitamin D 500 IU with evening mealAI-extracted
Key inclusion· 3
- ✓Postmenopausal women with T-score <-2 at lumbar spine or femoral neck
- ✓At least 3 years past last menstrual period
- ✓Not on HRT, Raloxifene, or calcitonin for at least 6 months
Key exclusion· 2
- ✕Bisphosphonate use within the previous 12 months
- ✕Secondary causes of osteoporosis
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Changes in Bone Density, Radiographic Texture Analysis and Bone Turnover During Two Years of Antiresorptive Therapy for Postmenopausal Osteoporosis
In Brief
A clinical study evaluating Alendronate, Calcium Citrate, and 1 other intervention for Osteoporosis and Osteopenia. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if a new test for osteoporosis can be useful in monitoring treatment. We are studying a new method for examining the quality of bone by an experimental method of computerized analysis of radiographic images (x-ray pictures) of the heel.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoporosis, Osteopenia
CountriesUnited States
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2001
First PostedSep 2005
Primary CompletionDec 2009
TodayJul 2026
First PostedSep 5, 2005
Enrollment StartJul 1, 2001
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8.4 yearsPosted 20.8 years ago
Interventions
Alendronatedrug
alendronate 70 mg once weekly
Calcium Citratedietary
600 mg of calcium citrate
Vitamin Ddietary
500 mg of Vitamin D consumed with the evening meal.